Department of Dermatology, Canterbury District Health Board, Christchurch, New Zealand.
Clin Exp Dermatol. 2012 Jun;37(4):358-60. doi: 10.1111/j.1365-2230.2011.04233.x. Epub 2011 Nov 21.
We present the case of a 41-year-old man who developed a photodistributed eruption 1 month after being started on 2-mercaptoethane sulfonate sodium (mesna) for treatment of cyclophosphamide-induced haemorrhagic cystitis. The patient had a background history of Wegener granulomatosis, and had been taking cyclophosphamide at a stable dose of 150 mg daily for the previous 3 years. Complete resolution of the rash occurred within 8 weeks of cessation of mesna. This is the first reported case, to our knowledge, of mesna-induced photodistributed dermatosis. Early recognition of this condition will ensure prompt cessation of the culprit medication, and consideration of alternative management of haemorrhagic cystitis.
我们报告了 1 例 41 岁男性患者的病例,他在开始使用巯乙磺酸钠(mesna)治疗环磷酰胺引起的出血性膀胱炎后 1 个月出现了光分布性皮疹。该患者有韦格纳肉芽肿的病史,并且在过去 3 年中每天稳定服用 150mg 的环磷酰胺。停止使用 mesna 后 8 周内皮疹完全消退。据我们所知,这是首例报道的 mesna 诱导的光分布性皮肤病。早期识别这种情况将确保及时停止使用罪魁祸首药物,并考虑替代治疗出血性膀胱炎的方法。